Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliano Moreira

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Chemico-Biological Interactions|September 7, 2024
Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studiesRayla Rodrigues Soares, Larissa Freitas Viggiani, Juliano Moreira Reis Filho, et al.
Life Sciences|April 15, 2026
Intermittent fasting and cardiometabolic responses under cardiac stress: a systematic review of preclinical studiesGabriel Almeida Sousa, Juliano Moreira Reis Filho, Humberto Batista, et al.
Journal of Evaluation in Clinical Practice|May 3, 2026
ChatGPT in Public Cardiovascular Healthcare: Accuracy, Limitations, and ImplicationsLara Borja Mialarett, Thiago Lott Bezerra, Manuela Carneiro Lopes, et al.
Scientific Reports|March 3, 2026
Empagliflozin and intermittent fasting as a strategy to mitigate anthracycline-induced cardiotoxicityJuliano Moreira Reis Filho, Ivan Lobo de Sousa Marques, Lucas Miranda Kangussu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Chemico-Biological Interactions|September 7, 2024
Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studiesRayla Rodrigues Soares, Larissa Freitas Viggiani, Juliano Moreira Reis Filho, et al.
Life Sciences|April 15, 2026
Intermittent fasting and cardiometabolic responses under cardiac stress: a systematic review of preclinical studiesGabriel Almeida Sousa, Juliano Moreira Reis Filho, Humberto Batista, et al.
Journal of Evaluation in Clinical Practice|May 3, 2026
ChatGPT in Public Cardiovascular Healthcare: Accuracy, Limitations, and ImplicationsLara Borja Mialarett, Thiago Lott Bezerra, Manuela Carneiro Lopes, et al.
Scientific Reports|March 3, 2026
Empagliflozin and intermittent fasting as a strategy to mitigate anthracycline-induced cardiotoxicityJuliano Moreira Reis Filho, Ivan Lobo de Sousa Marques, Lucas Miranda Kangussu, et al.
Pageof 1